Rupert Leong MBBS (UWA), FRACP, MD, AGAF
Clinical Professor of Medicine at University of Sydney and UNSWSydney, Australia
The agenda for this LIVE webinar includes a 40-minute presentation on "Safety of IBD Treatment: How to Manage Complications While on Treatment?" and a 20-minute Q&A session with Professor Rupert Leong.
As the therapeutic armamentarium for IBD grows, it is increasingly important to gain an understanding of the safety profiles of IBD medications. Although the clinical efficacy in IBD has been clearly established, it remains uncertain to what extent biologic and small molecule therapies might be associated with an increase in the rate of infections and malignancies among others.
In this presentation, we will discuss some of the safety analysis on advance therapies and how we can manage these safety issues that emerge for IBD patients who are on treatment.
Prof. Rupert Leong is a Senior Staff Specialist gastroenterologist, Director of Endoscopy and Head of the Inflammatory Bowel Disease Service at Concord Hospital, Clinical Professor of Medicine at University of Sydney and UNSW, and founding director of IBD Sydney, Australia.
He has an international reputation for the management of inflammatory bowel diseases. Prof. Leong has made a substantial contribution to research with over 150 high-quality scientific journals publications.
Prof. Leong was awarded the American Gastroenterological Association Fellowship by invitation on the basis of research excellence in 2012 and the UNSW Paper of the Year Prize in 2015.
To access this presentation, please login and click on the 'ENROLL TO WATCH' blue button by the right, on this page. To create a new account, please click here.
